Richter transformation develops in 2%–10% of CLL cases, often with rapid clinical decline, limited chemotherapy efficacy, and ...

As employers grapple with the soaring demand for glucagon-like peptide-1 (GLP-1) medications, Eric Levin, CEO and cofounder ...

Personal factors explained significant variance in five of six participation outcomes (R² 13%–48%), while environmental factors added ~11% for satisfaction and ~11% for GPS-based activity. Perceived ...

Clinical measures and biomarkers during pregnancy, including hs-cTnI and sFlt-1, can help identify women at higher risk of developing cardiovascular disease later in life.

Among patients with steatotic liver disease (SLD), patients with alcohol-associated liver disease (ALD) carry the highest risk of cirrhosis, followed by those with metabolic dysfunction–associated ...

Elona Toska, MSc, DPhil, explores drivers of HIV in pregnant women and young mothers: biology, relationships, and postpartum ...

Patients taking ACE inhibitors and ARBs saw a 16% reduction in their risk of cancer progression (HR, 0.84; 95% CI, 0.71-0.99; ...

Rural cardiovascular disparities and limited specialist access are motivating AI decision-support adoption to help determine ...

Noel T. Brewer, PhD, former ACIP member, warns that the CDC's reduction from 17 to 11 recommended immunizations lacks ...

In this episode, Overcoming Access Barriers and Step-Edit Challenges in IgA Nephropathy Care, the panelists explore the ...

Affordability dominated GLP-1 decision-making, with many paying >$250 per fill, widespread use of coupons, and strong ...

Noel T. Brewer, PhD, former ACIP member, warns that the CDC's reduction from 17 to 11 recommended immunizations lacks transparency, which may lower uptake.